APA

Colombel J., Jharap B., Sandborn W. J., Feagan B., Peyrin-Biroulet L., Eichner S. F., Robinson A. M., Mostafa N. M., Zhou Q. & Thakkar R. B. (20170829). Effects of concomitant immunomodulators on the pharmacokinetics, efficacy and safety of adalimumab in patients with Crohn's disease or ulcerative colitis who had failed conventional therapy. : Alimentary pharmacology & therapeutics.

Chicago

Colombel J-F, Jharap B, Sandborn W J, Feagan B, Peyrin-Biroulet L, Eichner S F, Robinson A M, Mostafa N M, Zhou Q and Thakkar R B. 20170829. Effects of concomitant immunomodulators on the pharmacokinetics, efficacy and safety of adalimumab in patients with Crohn's disease or ulcerative colitis who had failed conventional therapy. : Alimentary pharmacology & therapeutics.

Harvard

Colombel J., Jharap B., Sandborn W. J., Feagan B., Peyrin-Biroulet L., Eichner S. F., Robinson A. M., Mostafa N. M., Zhou Q. and Thakkar R. B. (20170829). Effects of concomitant immunomodulators on the pharmacokinetics, efficacy and safety of adalimumab in patients with Crohn's disease or ulcerative colitis who had failed conventional therapy. : Alimentary pharmacology & therapeutics.

MLA

Colombel J-F, Jharap B, Sandborn W J, Feagan B, Peyrin-Biroulet L, Eichner S F, Robinson A M, Mostafa N M, Zhou Q and Thakkar R B. Effects of concomitant immunomodulators on the pharmacokinetics, efficacy and safety of adalimumab in patients with Crohn's disease or ulcerative colitis who had failed conventional therapy. : Alimentary pharmacology & therapeutics. 20170829.